92 results on '"Flaherman, Valerie"'
Search Results
2. Patterns of peripartum depression and anxiety during the pre-vaccine COVID-19 pandemic
3. ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation—Revised 2017
4. LB01 Development of post-acute sequelae of SARS-CoV-2 (PASC) after infection in pregnancy: NIH RECOVER-Pregnancy Cohort
5. Breastfeeding and Once-Daily Small-Volume Formula Supplementation to Prevent Infant Growth Impairment
6. Physician personal breastfeeding experience and clinical care of the breastfeeding dyad
7. Newborn weight nomograms in selected low and middle-income countries
8. Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection
9. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
10. Researching COVID to enhance recovery (RECOVER) pregnancy study: Rationale, objectives and design
11. Admission and Care Practices in United States Well Newborn Nurseries
12. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis
13. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis
14. Milk antibody response after 3rd dose of COVID-19 mRNA vaccine and SARS-CoV-2 breakthrough infection and implications for infant protection
15. Patterns of Peripartum Depression and Anxiety During the Pre-Vaccine COVID-19 Pandemic
16. Dietary Energy
17. Experiences and attitudes related to newborn feeding in central Uganda: A qualitative study
18. Early infant growth impairment in the setting of frequent exclusive breast feeding: considering therapeutic options
19. Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy
20. Newborn weight change and predictors of underweight in the neonatal period in Guinea‐Bissau, Nepal, Pakistan and Uganda
21. Neutralizing antibody activity against SARS-CoV-2 variants in gestational age–matched mother-infant dyads after infection or vaccination
22. Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods
23. Clinical Decision Support for Newborn Weight Loss: A Randomized Controlled Trial
24. Randomized controlled trial of early, small-volume formula supplementation among newborns: A study protocol
25. Milk Antibody Response after 3rd Dose of COVID-19 mRNA Vaccine and SARS-CoV-2 Breakthrough Infection and Implications for Infant Protection
26. Milk Antibody Response After 3rd Dose of COVID-19 mRNA Vaccine and SARS-CoV-2 Breakthrough Infection and Implications for Infant Protection
27. Evaluating COVID-19 Vaccine-Related Messenger RNA in Breast Milk—Reply
28. Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies
29. Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancy
30. Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancy
31. Neutralizing Antibody Activity Against SARS-CoV-2 Variants in Gestational Age-Matched Mother-Infant Dyads
32. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads
33. Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk
34. Risk of pregnancy loss before 20 weeks’ gestation in study participants with COVID-19
35. Human Milk for the Term Newborn
36. Practice Variations in Diagnosis and Treatment of Hypoglycemia in Asymptomatic Newborns
37. Optimizing Neonatal Nutrition in Resource-Constrained Settings
38. COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyads
39. COVID-19 mRNA vaccine is not detected in human milk
40. Why you should share your data during a pandemic
41. Transient Effect of Infant Formula Supplementation on the Intestinal Microbiota
42. Protocol for a sequential, prospective meta-analysis to describe coronavirus disease 2019 (COVID-19) in the pregnancy and postpartum periods
43. Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People
44. Infant Outcomes Following Maternal Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): First Report From the Pregnancy Coronavirus Outcomes Registry (PRIORITY) Study
45. Supplementation Practices and Donor Milk Use in US Well-Newborn Nurseries
46. Randomized Controlled Trials of Electronic Health Record Interventions: Design, Conduct, and Reporting Considerations
47. Initial Weight Loss Among Breastfed Ugandan Neonates and Its Association with Subsequent Growth
48. Variation in Management of Cutaneous Lumbosacral Findings in Newborns
49. Attitudes and Experiences Related to Feeding in Early Infancy in Guinea-Bissau
50. Minimizing the Relationship Between Early Formula Use and Breastfeeding Cessation by Limiting Formula Volume
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.